Custom XCE Tirzepatide Manufacturing with Pharmaceutical Grade

XCE Tirzepatide (LY3298176) is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. This synthetic peptide demonstrates significant potential in metabolic research applications.

The compound works by simultaneously activating both GIP and GLP-1 receptors, which may lead to enhanced glucose-dependent insulin secretion and reduced glucagon secretion. Research suggests this dual mechanism could offer advantages in metabolic studies compared to single-receptor agonists.

Our XCE Tirzepatide is synthesized under strict quality control measures to ensure high purity and consistent performance in research settings. The white to off-white powder is supplied in sterile vials with optional custom packaging available.

Important Note: This product is intended for laboratory research use only. Not for human consumption or diagnostic use. Proper handling procedures should be followed by qualified researchers.